FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

ValueSets

84,592 resources (JSON | CSV)

By Version

R2: 25
R2B: 0
R3: 7,398
R4: 53,095
R4B: 14,934
R5: 8,882
R6: 143

By Authority

none: 44,145
hl7: 38,380
ihe: 143
national: 1,376
who: 548

By Realm

none: 41,876
au: 99
be: 131
br: 122
ca: 515
ch: 416
cl: 162
cr: 14
cz: 103
de: 575
dk: 498
ee: 35
eu: 386
fi: 4
fr: 909
il: 161
in: 48
it: 92
jp: 71
kr: 20
nl: 916
no: 16
nz: 9
pl: 70
pt: 3
se: 16
tw: 220
us: 14,248
uv: 22,853
other: 4

Start Prev Rows 39200 - 39400 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth	Source(s)	Usage #
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.127.json	ICD10 CM Hypertriglyceridemia	active	2024-12	us	hl7	icd	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.129.json	AHA GWTG Hypertriglyceridemia	active	2024-11	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.130.json	SNOMED CT Gestational Diabetes	active	2024-12	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.131.json	ICD10 CM Gestational Diabetes	active	2024-12	us	hl7	icd	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.132.json	AHA GWTG Gestational Diabetes	active	2024-11	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.133.json	SNOMED CT Hyperglycemia	active	2024-12	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.134.json	ICD10 CM Hyperglycemia	active	2024-12	us	hl7	icd	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.135.json	AHA GWTG Hyperglycemia	active	2024-11	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.136.json	SNOMED CT Nonobstructive CAD	active	2024-12	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.137.json	ICD10 CM Nonobstructive Coronary Artery Disease	active	2024-12	us	hl7	icd	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.138.json	AHA GWTG Nonobstructive coronary artery disease	active	2024-11	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.139.json	AHA GWTG Anti Obesity Pharmacotherapy	active	2024-12	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.15.json	Non Tobacco Smoking Product User	active	2024-02	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.16.json	Antihypertensive Fixed Dose Combination Medications	active	2024-02	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.2.json	PCSK9 Inhibitors	active	2023-02	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.20.json	CCB and Thiazide and Thiazide Like Diuretics	active	2021-01	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.21.json	Referral to cardiac rehab	active	2021-04	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.22.json	Cardiac Rehabilitation	active	2021-04	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.25.json	2 Hour Blood Glucose Test	active	2022-07	us	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.26.json	NYHA Functional Classification	active	2022-07	us	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.27.json	ARNI Therapy	active	2022-07	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.29.json	MRA Therapy	active	2022-07	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.3.json	Cholesterol non HDL Laboratory Test	active	2021-04	us	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.30.json	SGLT2 Inhibitors	active	2024-02	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.31.json	Heart Transplant	active	2022-02	us	hl7	cpt	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.32.json	Heart Transplant	active	2022-02	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.33.json	Heart Transplant	active	2022-02	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.34.json	Allergy to MRA Therapy	active	2024-02	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.35.json	Aspirin or Clopidogrel	active	2024-02	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.39.json	Cardiac Rehabilitation	active	2024-01	us	hl7	cpt	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.4.json	Hypothyroidism	active	2021-04	us	hl7	icd	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.40.json	Cardiac Rehabilitation	active	2022-07	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.43.json	SGLT2 Ingredients	active	2022-07	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.44.json	MRA Ingredients	active	2022-07	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.49.json	Minnesota Living with Heart Failure Questionnaire	active	2022-07	us	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.5.json	Hypothyroidism	active	2024-02	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.50.json	Kansas City Cardiomyopathy Questionnaire	active	2022-07	us	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.51.json	Cardiac Pacer	active	2021-11	us	hl7	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.52.json	Cardiac Pacer	active	2025-01	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.53.json	Cardiac Pacer	active	2022-02	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.54.json	Heart Transplant Complications	active	2022-03	us	hl7	icd	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.55.json	Heart Transplant Complications	active	2025-01	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.56.json	Heart Transplant Complications	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.57.json	Left Ventricular Assist Device Complications	active	2022-02	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.58.json	Left Ventricular Assist Device Complications	active	2022-02	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.59.json	Left Ventricular Assist Device Placement	active	2023-02	us	hl7	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.6.json	Hypothyroidism	active	2021-04	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.60.json	Left Ventricular Assist Device Placement	active	2023-02	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.61.json	Left Ventricular Assist Device Placement	active	2022-02	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.62.json	Left Ventricular Assist Device Placement	active	2022-02	us	hl7	cpt	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.63.json	Heart Transplant	active	2022-07	us	hl7	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.65.json	Cardiac Pacer	active	2022-11	us	hl7	cpt	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.66.json	Diastolic Heart Failure	active	2023-06	us	hl7	icd	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.67.json	Diastolic Heart Failure	active	2023-06	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.68.json	Diastolic Heart Failure	active	2022-02	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.69.json	Allergy to SGLT2 Inhibitors	active	2023-02	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.7.json	Anorexia Nervosa	active	2023-02	us	hl7	icd	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.70.json	Intolerance to SGLT2 Inhibitors	active	2022-07	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.71.json	Intolerance to MRA Therapy	active	2022-07	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.72.json	ARNI Ingredient	active	2022-02	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.73.json	Mitral Stenosis	active	2022-02	us	hl7	icd	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.74.json	Mitral Stenosis	active	2022-02	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.75.json	Mitral Stenosis	active	2022-02	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.76.json	Mechanical Prosthetic Heart Valve	active	2022-11	us	hl7	cpt	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.77.json	Mechanical Prosthetic Heart Valve	active	2025-04	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.78.json	Mechanical Prosthetic Heart Valve	active	2022-02	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.79.json	Mechanical Prosthetic Heart Valve in Situ	active	2022-02	us	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.8.json	Anorexia Nervosa	active	2021-04	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.82.json	Systolic Heart Failure	active	2023-03	us	hl7	icd	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.83.json	Systolic Heart Failure	active	2023-03	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.84.json	Systolic Heart Failure	active	2023-03	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.85.json	Carotid Intervention	active	2023-03	us	hl7	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.86.json	Serum Creatinine	active	2023-10	us	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.87.json	Urine Creatinine	active	2025-03	us	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.88.json	Urine Albumin	active	2023-10	us	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.9.json	Anorexia Nervosa	active	2021-04	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.90.json	Non Steroidal Mineralcorticoid Receptor Antagonist	active	2024-10	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.91.json	Glucagon like peptide 1 medications	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1178.96.json	AHA GWTG Long COVID19	active	2024-10	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.1.json	Wound internal item and/or body structure visible value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.11.json	Wound exudate appearance value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.12.json	Wound exudate color value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.13.json	Exudate odor value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.16.json	Skin temperature value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.17.json	Skin color enumerated value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.18.json	Skin turgor value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.19.json	Skin and mucous membrane integrity value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.2.json	Periwound condition value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.20.json	Skin moisture value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.3.json	Wound Type Etiology value set	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.4.json	Wound episode value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.6.json	Wound bed appearance value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.60.json	Wound type reference set	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.7.json	Wound bed color value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.74.json	Nonverbal pain indicators reference set	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.76.json	Pain associated signs and symptoms reference set	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.77.json	Pain body location reference set	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.8.json	Wound edge description value set (foundation metadata concept)	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.80.json	Pain quality reference set	active	2025-03	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.81.json	Pain speed of onset reference set	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1181.9.json	Presence absence value set (foundation metadata concept)	active	2018-07	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1186.1.json	Common drug substances for allergy and intolerance documentation	active	2024-06	us	hl7	rx	2
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1186.2.json	Common drug classes for allergy and intolerance documentation	active	2024-06	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1186.3.json	Common dietary substances for allergy and intolerance documentation	active	2024-06	us	hl7	sct	2
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1186.4.json	Common environmental substances for allergy and intolerance documentation	active	2024-06	us	hl7	sct	2
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.10.json	NHSNCriterionOfDiagnosisCode(CDCNHSN)	active	2020-08	us	hl7	cdc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.11.json	NHSNCriterionOfDiagnosisCode(SNOMEDCT)	active	2020-08	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.12.json	NHSNInfectionConditionCode(CDCNHSN)	active	2020-08	us	hl7	cdc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.13.json	NHSNInfectionConditionCode(SNOMEDCT)	active	2020-08	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.14.json	NHSNInfectionTypeCode(CDCNHSN)	active	2020-08	us	hl7	cdc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.15.json	NHSNInfectionTypeCode(SNOMEDCT)	active	2020-08	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.16.json	NHSNInfectionFirstReportedSource(CDCNHSN)	active	2020-08	us	hl7	cdc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.17.json	NHSNInfectionFirstReportedSource(SNOMEDCT)	active	2020-08	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.18.json	NHSNLOS/MENDischargeDisposition(CDCNHSN)	active	2020-08	us	hl7	cdc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.19.json	NHSNLOS/MENDischargeDisposition(SNOMEDCT)	active	2020-08	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.20.json	NHSNPopulationSummaryReportTypeCode(CDCNHSN)	active	2020-08	us	hl7	cdc	3
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.21.json	NHSNPopulationSummaryReportTypeCode(LOINC)	active	2020-08	us	hl7	loinc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.22.json	NHSNSameDayOutcomeMeasure(CDCNHSN)	active	2020-08	us	hl7	cdc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.23.json	NHSNSameDayOutcomeMeasure(SNOMEDCT)	active	2020-08	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.24.json	NHSNSignificantPathogenCode(CDCNHSN)	active	2020-08	us	hl7	cdc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.25.json	NHSNSignificantPathogenCode(SNOMEDCT)	active	2020-08	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.26.json	NHSNSpinalFusionApproachCode(CDCNHSN)	active	2020-08	us	hl7	cdc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.27.json	NHSNSpinalFusionApproachCode(SNOMEDCT)	active	2020-08	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.28.json	NHSNVascularAccessTypeCode(CDCNHSN)	active	2020-08	us	hl7	cdc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.29.json	NHSNVascularAccessTypeCode(SNOMEDCT)	active	2020-08	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.30.json	NHSNVascularSpecimenCollectionSite(CDCNHSN)	active	2020-08	us	hl7	cdc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.31.json	NHSNVascularSpecimenCollectionSite(SNOMEDCT)	active	2020-08	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.38.json	Blood Glucose Laboratory and Point of Care Tests	active	2023-09	us	hl7	loinc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.6.json	NHSNPathogenCodeARO	active	2025-03	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.63.json	Bacterial and Fungal Blood Culture Tests	active	2022-07	us	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.7.json	NHSNRoleOfPerformerCode(CDCNHSN)	active	2020-08	us	hl7	cdc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.74.json	Enteral Medication Route	active	2022-07	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.75.json	Intravenous Medication Route	active	2022-07	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.79.json	Fidaxomicin, Vancomycin, and Metronidazole	active	2022-07	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.8.json	NHSNRoleOfPerformerCode(SNOMEDCT)	active	2020-08	us	hl7	sct	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.85.json	Baloxavir	active	2023-05	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.86.json	Peramivir	active	2023-05	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.87.json	Zanamivir	active	2023-05	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.88.json	Digestive, Intramuscular, Intravenous Route of Administration	active	2023-10	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.9.json	NHSNRoleOfPerformerCode(HealthCareProviderTaxonomy)	active	2020-08	us	hl7	nucc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.90.json	NHSN LTC AU Antimicrobial Agents	active	2024-05	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.91.json	Long Term Care Discharge Disposition	active	2024-01	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.94.json	NHSNNeurogenicBladder	active	2025-03	us	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1190.95.json	NHSNSpinalCordInjury	active	2025-03	us	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.147.json	SCIP Major Surgical Procedure	active	2019-06	us	hl7	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.3483.json	Financial Insecurity Screening Assessments Questions	active	2023-07	us	hl7	loinc	3
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.3484.json	Food Insecurity Screening Assessments Questions	active	2023-07	us	hl7	loinc	3
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.3485.json	Health Literacy Screening Assessments Questions	active	2024-12	us	hl7	loinc	3
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.3486.json	Homelessness Screening Assessments Questions	active	2023-08	us	hl7	loinc	3
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.3487.json	Housing Instability Screening Assessments Questions	active	2023-08	us	hl7	loinc	3
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.3488.json	Less Than High School Education Screening Assessments Questions	active	2023-07	us	hl7	loinc	3
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.3519.json	Health Insurance Coverage Status Screening Assessments And Questions	active	2023-07	us	hl7	vsac	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.3520.json	Inadequate Housing Screening Assessments And Questions	active	2023-07	us	hl7	vsac	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.393.json	Hypoglycemics Severe Hypoglycemia	active	2024-01	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.394.json	Hypoglycemics Treatment Medications	active	2025-02	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.4448.json	Lidocaine	active	2024-05	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.491.json	Medium Dose ICS Formoterol Preparations	active	2021-09	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.495.json	ICS LABA LAMA Preparations	active	2021-09	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1196.788.json	Social Determinants of Health Conditions	active	2024-12	us	hl7	vsac	2
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.15.json	General Surgery	active	2020-04	us	hl7	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.17.json	Coagulation Disorder Conditions	active	2020-04	us	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.19.json	Anticoagulant Medications	active	2025-02	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.20.json	Anticoagulant Medications, Oral	active	2024-03	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.21.json	Anticoagulant Medications, Injection	active	2024-03	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.28.json	Active Bleeding	active	2020-11	us	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.29.json	Fall Risk Increasing Drugs (FRIDs)	active	2021-07	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.30.json	Fall Risk Factors	active	2021-02	us	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.32.json	Total Hip Arthroplasty Surgery	active	2021-03	us	hl7	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.33.json	Total Knee Arthroplasty Surgery	active	2021-03	us	hl7	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.46.json	Opioid Medications	active	2021-07	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.47.json	Imaging Related to VTE	active	2023-01	us	hl7	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.48.json	Anticoagulant Medication	active	2024-03	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.49.json	VTE Diagnoses	active	2025-02	us	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.50.json	Bisphosphonate Therapy	active	2022-02	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.51.json	VTE Symptoms	active	2022-03	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.52.json	Oncology Critical Care Units	active	2022-03	us	hl7	cdc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.53.json	Provider Types	active	2022-05	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.56.json	FOBT_Lab	active	2024-07	us	hl7	cpt	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.58.json	Screening Mammogram (CPT)	active	2024-08	us	hl7	cpt	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.59.json	Screening Mammogram (LOINC)	active	2024-09	us	hl7	loinc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.60.json	Screening Mammogram (SNOMEDCT)	active	2024-08	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.61.json	Screening Mammogram (Grouping)	active	2024-08	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.62.json	Diagnostic Mammography (CPT)	active	2024-08	us	hl7	cpt	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.63.json	Diagnostic Mammography (LOINC)	active	2024-09	us	hl7	loinc	1
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.64.json	Diagnostic Mammography (SNOMEDCT)	active	2024-08	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.65.json	Diagnostic Mammography	active	2024-08	us	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.66.json	Breast Cancer Biopsy and Surgical Excision	active	2024-10	us	hl7	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.67.json	BI_RADS Categories 0, 4, and 5	active	2024-10	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1206.68.json	BI_RADS Categories 1, 2, and 3	active	2024-10	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1213.101.json	Local Anesthetics	active	2023-07	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1213.102.json	Ophthalmic Epinephrines	active	2023-07	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1213.103.json	Inhaled Epinephrines	active	2023-07	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1213.104.json	Clopidogrels	active	2023-10	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1213.105.json	Cytochrome P450 2C19 inhibitors	active	2023-10	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1213.107.json	Aspirin Ingredient and Risk of GI Bleeding	active	2023-12	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1213.109.json	Oral Anticoagulant Ingredients and Risk of GI Bleeding	active	2023-12	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1213.112.json	PPI and Risk of GI Bleeding	active	2023-12	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1213.113.json	Antiplatelet Ingredients and Risk of GI Bleeding	active	2023-12	us	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1213.115.json	Kratom containing compounds	active	2024-07	us	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1213.117.json	Clopidogrel Ingredients and Risk of GI Bleeding	active	2024-09	us	hl7	rx